Lignan Intake and Mortality Among Adults with Incident Type 2 Diabetes-Prospective Cohort Studies.

Binkai Liu, Yang Hu, Siyue Wang, Molin Wang, Eric B Rimm, Qi Sun
Author Information
  1. Binkai Liu: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  2. Yang Hu: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  3. Siyue Wang: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  4. Molin Wang: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  5. Eric B Rimm: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
  6. Qi Sun: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States. Electronic address: qisun@hsph.harvard.edu.

Abstract

BACKGROUND: Lignans are polyphenolic compounds abundant in plant-based foods such as seeds, whole grains, and certain fruits and vegetables and may lead to favorable metabolic health. It remains to be elucidated regarding the role of lignan consumption in the etiology of premature deaths among individuals with diabetes.
OBJECTIVES: To prospectively examine the association between postdiagnosis lignan intake and mortality among individuals with type 2 diabetes (T2D).
METHODS: We analyzed data from 2 prospective United States cohorts, the Nurses' Health Study (1984-2020) and Health Professionals Follow-up Study (1986-2022). Mean daily consumption of total and individual lignans was calculated, and postdiagnosis lignan intakes were cumulatively averaged. Multivariable-adjusted Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between lignan intake and mortality.
RESULTS: Among 8465 incident T2D cases contributing 116,026 person-years of follow-up, 4372 deaths were documented, including 1318 from cardiovascular disease (CVD) and 752 from cancer. The pooled multivariable-adjusted HRs (95% CIs) of all-cause mortality comparing the highest compared with the lowest quintiles of postdiagnosis lignan intake were 0.83 (0.74, 0.94) for total lignans, 0.89 (0.80, 0.99) for matairesinol (MAT), 0.78 (0.69, 0.87) for secoisolariciresinol (SECO), 0.91 (0.81, 1.01) for pinoresinol (PINO), and 0.92 (0.82, 1.03) for lariciresinol (LARIC). Higher postdiagnosis SECO intake was also significantly associated with lower CVD and cancer mortality. Changes in lignan intake from pre- to postdiagnosis showed similar favorable associations: 0.83 (0.75, 0.93) for total lignans, 0.86 (0.77, 0.96) for MAT, and 0.81 (0.72, 0.90) for SECO. The associations of lignan intake were significantly stronger among nonwhite individuals.
CONCLUSIONS: Among individuals with T2D, a higher intake of lignans, particularly SECO, was significantly associated with reduced overall CVD and cancer mortality. Minority groups may particularly benefit from lignan intake, although further studies are warranted to substantiate this observation.

Keywords

References

  1. J Endocrinol. 1995 Nov;147(2):295-302 [PMID: 7490559]
  2. Diabetes Care. 2014;37(5):1287-95 [PMID: 24550220]
  3. BMC Microbiol. 2022 Mar 29;22(1):82 [PMID: 35350985]
  4. Lancet. 1991 Sep 28;338(8770):774-8 [PMID: 1681160]
  5. Am J Epidemiol. 2017 Jun 15;185(12):1304-1316 [PMID: 28472215]
  6. Nutr Rev. 2010 Oct;68(10):571-603 [PMID: 20883417]
  7. JAMA. 2002 Dec 4;288(21):2709-16 [PMID: 12460094]
  8. PLoS One. 2007 Nov 07;2(11):e1148 [PMID: 17987126]
  9. Br J Nutr. 2009 Apr;101(8):1145-9 [PMID: 18775100]
  10. Diabetes Care. 2013 Dec;36(12):3961-70 [PMID: 24130345]
  11. Am J Clin Nutr. 2023 Jan;117(1):130-140 [PMID: 36789932]
  12. J Am Coll Cardiol. 2021 Aug 17;78(7):666-678 [PMID: 34384548]
  13. Circulation. 2010 May 25;121(20):2162-8 [PMID: 20458012]
  14. Med Sci Sports Exerc. 1993 Jan;25(1):71-80 [PMID: 8292105]
  15. Crit Rev Clin Lab Sci. 2007;44(5-6):483-525 [PMID: 17943494]
  16. Diabetologia. 2006 Nov;49(11):2618-26 [PMID: 17019600]
  17. Lancet. 1991 Aug 24;338(8765):464-8 [PMID: 1678444]
  18. Am J Epidemiol. 1994 Dec 1;140(11):1016-9 [PMID: 7985649]
  19. Am J Clin Nutr. 2006 Aug;84(2):400-5 [PMID: 16895890]
  20. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):205-12 [PMID: 8049151]
  21. Am J Epidemiol. 1984 May;119(5):837-9 [PMID: 6720679]
  22. Circulation. 2005 Feb 1;111(4):465-71 [PMID: 15687135]
  23. J Nutr. 2008 Apr;138(4):775-81 [PMID: 18356334]
  24. Arch Intern Med. 2001 Jun 25;161(12):1542-8 [PMID: 11427103]
  25. Epidemiology. 1990 Nov;1(6):466-73 [PMID: 2090285]
  26. BMC Med. 2014 May 13;12:77 [PMID: 24886552]
  27. Nutr Res. 2023 Feb;110:23-32 [PMID: 36640581]
  28. Crit Rev Food Sci Nutr. 2017 Mar 24;57(5):975-986 [PMID: 25746842]
  29. Am J Epidemiol. 1985 Jul;122(1):51-65 [PMID: 4014201]
  30. Nat Commun. 2023 Jul 18;14(1):4316 [PMID: 37463879]
  31. Stat Med. 1989 May;8(5):551-61 [PMID: 2657958]
  32. J Womens Health. 1997 Feb;6(1):49-62 [PMID: 9065374]
  33. Circ Res. 2019 Mar 15;124(6):920-929 [PMID: 30776978]
  34. Epidemiology. 1996 Jan;7(1):81-6 [PMID: 8664406]
  35. Nutrients. 2023 Mar 15;15(6): [PMID: 36986142]
  36. Epidemiology. 2013 Sep;24(5):726-33 [PMID: 23881072]
  37. J Am Coll Cardiol. 2018 Jun 26;71(25):2867-2876 [PMID: 29929608]
  38. JAMA Netw Open. 2024 Aug 1;7(8):e2426367 [PMID: 39110458]
  39. Food Chem Toxicol. 2012 Oct;50(10):3680-6 [PMID: 22819933]
  40. Diabetes Care. 2020 Jan;43(Suppl 1):S48-S65 [PMID: 31862748]
  41. PLoS One. 2010 Feb 05;5(2):e9085 [PMID: 20140211]

Grants

  1. P01 CA087969/NCI NIH HHS
  2. R01 DK126698/NIDDK NIH HHS
  3. U01 CA167552/NCI NIH HHS
  4. R01 HL096905/NHLBI NIH HHS
  5. R01 HL060712/NHLBI NIH HHS
  6. R01 HL034594/NHLBI NIH HHS
  7. UM1 CA186107/NCI NIH HHS
  8. R01 HL035464/NHLBI NIH HHS
  9. U2C DK129670/NIDDK NIH HHS

MeSH Term

Humans
Lignans
Diabetes Mellitus, Type 2
Prospective Studies
Female
Male
Middle Aged
Adult
Diet
United States
Cohort Studies
Aged
Incidence

Chemicals

Lignans

Word Cloud

Created with Highcharts 10.0.00lignanintakemortalitypostdiagnosislignansindividuals2SECOamongdiabetesT2DtotalAmongCVDcancersignificantlymayfavorablehealthconsumptiondeathstypeprospectivecohortsHealthStudyHRs95%CIsassociations83MAT811associatedparticularlyBACKGROUND:Lignanspolyphenoliccompoundsabundantplant-basedfoodsseedswholegrainscertainfruitsvegetablesleadmetabolicremainselucidatedregardingroleetiologyprematureOBJECTIVES:prospectivelyexamineassociationMETHODS:analyzeddataUnitedStatesNurses'1984-2020ProfessionalsFollow-up1986-2022MeandailyindividualcalculatedintakescumulativelyaveragedMultivariable-adjustedCoxmodelsusedestimatehazardratiosconfidenceintervalsRESULTS:8465incidentcasescontributing116026person-yearsfollow-up4372documentedincluding1318cardiovasculardisease752pooledmultivariable-adjustedall-causecomparinghighestcomparedlowestquintiles7494898099matairesinol786987secoisolariciresinol9101pinoresinolPINO928203lariciresinolLARICHigheralsolowerChangespre-showedsimilarassociations:75938677967290strongernonwhiteCONCLUSIONS:higherreducedoverallMinoritygroupsbenefitalthoughstudieswarrantedsubstantiateobservationLignanIntakeMortalityAdultsIncidentTypeDiabetes-ProspectiveCohortStudiescardiometabolic

Similar Articles

Cited By